Multivariate analysis of metabolic state vulnerabilities across diverse cancer contexts reveals synthetically lethal associations
Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsuper...
Saved in:
Published in | Cell reports (Cambridge) Vol. 43; no. 10; p. 114775 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
22.10.2024
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 2211-1247 2639-1856 2211-1247 |
DOI | 10.1016/j.celrep.2024.114775 |
Cover
Abstract | Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsupervised and supervised multivariate modeling approaches to systematically pinpoint recurrent metabolic states within hundreds of cancer cell lines, elucidate their association with tumor lineage and growth environments, and uncover vulnerabilities linked to their metabolic states across diverse genetic and tissue contexts. We validate key findings via analysis of data from patient-derived tumors and pharmacological screens and by performing genetic and pharmacological experiments. Our analysis uncovers synthetically lethal associations between the tumor metabolic state (e.g., oxidative phosphorylation), driver mutations (e.g., loss of tumor suppressor PTEN), and actionable biological targets (e.g., mitochondrial electron transport chain). Investigating the mechanisms underlying these relationships can inform the development of more precise and context-specific, metabolism-targeted cancer therapies.
[Display omitted]
•Most metabolic pathway heterogeneities are cancer type specific; Oxphos variability is not•OxphosHigh and OxphosLow states show unique vulnerabilities independent of growth condition•PTEN loss increases OxphosHigh state’s dependency on mitochondrial electron transport chain•Oxphos inhibitors show higher potency in PTENNull glioma cells than in PTEN-expressing cells
Abecunas et al. use multivariate modeling to explore recurrent metabolic states in cancer cells and uncover synthetically lethal interactions across diverse metabolic, oncogenic, and tissue contexts. They validate key findings via independent data analysis and new experiments. They find that PTEN loss predicts increased dependency on mitochondrial respiratory chain in OxphosHigh tumor cells. |
---|---|
AbstractList | Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsupervised and supervised multivariate modeling approaches to systematically pinpoint recurrent metabolic states within hundreds of cancer cell lines, elucidate their association with tumor lineage and growth environments, and uncover vulnerabilities linked to their metabolic states across diverse genetic and tissue contexts. We validate key findings via analysis of data from patient-derived tumors and pharmacological screens and by performing genetic and pharmacological experiments. Our analysis uncovers synthetically lethal associations between the tumor metabolic state (e.g., oxidative phosphorylation), driver mutations (e.g., loss of tumor suppressor PTEN), and actionable biological targets (e.g., mitochondrial electron transport chain). Investigating the mechanisms underlying these relationships can inform the development of more precise and context-specific, metabolism-targeted cancer therapies. Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsupervised and supervised multivariate modeling approaches to systematically pinpoint recurrent metabolic states within hundreds of cancer cell lines, elucidate their association with tumor lineage and growth environments, and uncover vulnerabilities linked to their metabolic states across diverse genetic and tissue contexts. We validate key findings via analysis of data from patient-derived tumors and pharmacological screens and by performing genetic and pharmacological experiments. Our analysis uncovers synthetically lethal associations between the tumor metabolic state (e.g., oxidative phosphorylation), driver mutations (e.g., loss of tumor suppressor PTEN), and actionable biological targets (e.g., mitochondrial electron transport chain). Investigating the mechanisms underlying these relationships can inform the development of more precise and context-specific, metabolism-targeted cancer therapies. Abecunas et al. use multivariate modeling to explore recurrent metabolic states in cancer cells and uncover synthetically lethal interactions across diverse metabolic, oncogenic, and tissue contexts. They validate key findings via independent data analysis and new experiments. They find that PTEN loss predicts increased dependency on mitochondrial respiratory chain in OxphosHigh tumor cells. Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsupervised and supervised multivariate modeling approaches to systematically pinpoint recurrent metabolic states within hundreds of cancer cell lines, elucidate their association with tumor lineage and growth environments, and uncover vulnerabilities linked to their metabolic states across diverse genetic and tissue contexts. We validate key findings via analysis of data from patient-derived tumors and pharmacological screens and by performing genetic and pharmacological experiments. Our analysis uncovers synthetically lethal associations between the tumor metabolic state (e.g., oxidative phosphorylation), driver mutations (e.g., loss of tumor suppressor PTEN), and actionable biological targets (e.g., mitochondrial electron transport chain). Investigating the mechanisms underlying these relationships can inform the development of more precise and context-specific, metabolism-targeted cancer therapies.Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsupervised and supervised multivariate modeling approaches to systematically pinpoint recurrent metabolic states within hundreds of cancer cell lines, elucidate their association with tumor lineage and growth environments, and uncover vulnerabilities linked to their metabolic states across diverse genetic and tissue contexts. We validate key findings via analysis of data from patient-derived tumors and pharmacological screens and by performing genetic and pharmacological experiments. Our analysis uncovers synthetically lethal associations between the tumor metabolic state (e.g., oxidative phosphorylation), driver mutations (e.g., loss of tumor suppressor PTEN), and actionable biological targets (e.g., mitochondrial electron transport chain). Investigating the mechanisms underlying these relationships can inform the development of more precise and context-specific, metabolism-targeted cancer therapies. Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent nature of cancer cell metabolism, however, poses challenges to identifying effective therapeutic interventions. Here, we utilize various unsupervised and supervised multivariate modeling approaches to systematically pinpoint recurrent metabolic states within hundreds of cancer cell lines, elucidate their association with tumor lineage and growth environments, and uncover vulnerabilities linked to their metabolic states across diverse genetic and tissue contexts. We validate key findings via analysis of data from patient-derived tumors and pharmacological screens and by performing genetic and pharmacological experiments. Our analysis uncovers synthetically lethal associations between the tumor metabolic state (e.g., oxidative phosphorylation), driver mutations (e.g., loss of tumor suppressor PTEN), and actionable biological targets (e.g., mitochondrial electron transport chain). Investigating the mechanisms underlying these relationships can inform the development of more precise and context-specific, metabolism-targeted cancer therapies. [Display omitted] •Most metabolic pathway heterogeneities are cancer type specific; Oxphos variability is not•OxphosHigh and OxphosLow states show unique vulnerabilities independent of growth condition•PTEN loss increases OxphosHigh state’s dependency on mitochondrial electron transport chain•Oxphos inhibitors show higher potency in PTENNull glioma cells than in PTEN-expressing cells Abecunas et al. use multivariate modeling to explore recurrent metabolic states in cancer cells and uncover synthetically lethal interactions across diverse metabolic, oncogenic, and tissue contexts. They validate key findings via independent data analysis and new experiments. They find that PTEN loss predicts increased dependency on mitochondrial respiratory chain in OxphosHigh tumor cells. |
ArticleNumber | 114775 |
Author | Fallahi-Sichani, Mohammad Abecunas, Cara Kidd, Audrey D. Jiang, Ying Zong, Hui |
AuthorAffiliation | 4 UVA Comprehensive Cancer Center, University of Virginia, Charlottesville, VA 22908, USA 2 Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA 5 Present address: Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA 6 Lead contact 3 Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA 1 Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA |
AuthorAffiliation_xml | – name: 1 Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA – name: 5 Present address: Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA – name: 4 UVA Comprehensive Cancer Center, University of Virginia, Charlottesville, VA 22908, USA – name: 6 Lead contact – name: 3 Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA – name: 2 Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48109, USA |
Author_xml | – sequence: 1 givenname: Cara surname: Abecunas fullname: Abecunas, Cara organization: Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA – sequence: 2 givenname: Audrey D. surname: Kidd fullname: Kidd, Audrey D. organization: Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA – sequence: 3 givenname: Ying surname: Jiang fullname: Jiang, Ying organization: Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA – sequence: 4 givenname: Hui surname: Zong fullname: Zong, Hui organization: Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA – sequence: 5 givenname: Mohammad orcidid: 0000-0003-0917-3525 surname: Fallahi-Sichani fullname: Fallahi-Sichani, Mohammad email: fallahi@virginia.edu organization: Department of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39305483$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkU9v1DAQxSNUREvpN0AoRy67eGJ7nVxAqOJPpSIucLYmzqTrlddebG9gj3xzvE2p2gvCF1v2m_dm_HtenfjgqapeAlsCg9WbzdKQi7RbNqwRSwChlHxSnTUNwAIaoU4enE-ri5Q2rKwVA-jEs-qUd5xJ0fKz6veXvct2wmgxU40e3SHZVIex3lLGPjhr6pSPb9PeeYrYW2ezpVSjiSGlerATxUS1QW8o1ib4TL9yqiNNhC7V6eDzmrI16NyhdpTX6GpMKZiSaINPL6qnYxHSxd1-Xn3_-OHb5efF9ddPV5fvrxdGqC4vOICCVjXAuWkQUHZMlBkkddwgDaMyA_UIyqw63hoYWSu7oWetEC3jI0h-Xl3NvkPAjd5Fu8V40AGtvr0I8UZjLH060mboJJFkUqpBtCCwRd6ZnquWgWJMFS85e-39Dg8_y2j3hsD0kZDe6JmQPhLSM6FS926u2-37LQ2GfI7oHjXz-MXbtb4JU6mXACvOisPrO4cYfuwpZb21qSQ59BT2SXNgSrWyaIv01cOw-5S_8ItAzIJbkpHG_x3i7VxGhdZkKepkLBX6g41kcvlO-2-DP9MR3jo |
Cites_doi | 10.1186/s13059-021-02540-7 10.1016/0169-7439(93)E0075-F 10.1038/nchembio.1986 10.1093/nar/gkad986 10.1158/2159-8290.CD-20-0844 10.7171/jbt.18-2902-002 10.1016/j.trecan.2019.05.004 10.1038/s42255-021-00388-6 10.1158/0008-5472.CAN-22-0883 10.1093/nar/gkv1070 10.1016/j.celrep.2021.108750 10.1016/j.celrep.2021.109024 10.1371/journal.pone.0123721 10.1016/j.cell.2013.08.032 10.1186/s12915-019-0654-4 10.1038/s41586-019-0993-x 10.1038/s41587-020-0546-8 10.1016/j.celrep.2022.111818 10.1158/1078-0432.CCR-19-0032 10.1158/2159-8290.CD-12-0095 10.1038/s43018-020-00159-4 10.1038/s41591-022-02103-8 10.1038/s41591-019-0404-8 10.1038/s41467-021-26213-y 10.1038/s41586-019-1103-9 10.1038/s41586-023-05793-3 10.1038/s41467-021-27329-x 10.1038/s41467-018-04033-x 10.1038/s41467-021-22236-7 10.1186/s12859-021-04344-9 10.1016/j.bbcan.2018.05.002 10.1016/j.tcb.2021.05.003 10.1126/science.1236062 10.1158/2159-8290.CD-16-1034 10.1038/s41574-023-00833-4 10.1038/s41568-019-0226-5 10.1038/s41467-020-20294-x 10.1158/0008-5472.CAN-17-0165 10.1038/s41591-018-0052-4 10.1093/neuonc/now062 10.1126/science.aaf5171 10.1038/nature11003 10.1038/s42255-023-00817-8 10.1093/nar/gkw377 10.1002/gene.10036 10.1073/pnas.1921815117 10.15252/msb.202211033 10.1038/nprot.2011.319 10.1038/s41573-021-00339-6 10.1038/s41540-023-00305-5 10.1038/s41586-019-1186-3 10.1016/j.ccell.2022.10.009 10.1038/s41467-019-11738-0 10.1038/s41467-023-38360-5 10.1038/nchembio.94 10.1371/journal.pcbi.1008942 10.1186/s40170-021-00272-7 10.1038/ng.2764 10.1038/s41586-019-1775-1 10.1016/j.cell.2023.01.038 10.1038/s41586-023-06073-w 10.1038/s41392-022-01243-0 10.1038/nature22359 10.1016/j.cell.2011.06.014 10.1016/0076-6879(79)55061-7 10.1038/nbt.4314 10.1016/j.chom.2018.07.009 10.1038/s41588-020-00726-6 10.15252/msb.202211006 10.1038/s41416-023-02394-9 10.1038/s41467-023-43917-5 10.1016/j.celrep.2018.03.032 10.1038/s41467-020-18376-x |
ContentType | Journal Article |
Copyright | 2024 The Author(s) Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2024 The Author(s) – notice: Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved. |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY DOA |
DOI | 10.1016/j.celrep.2024.114775 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2211-1247 |
EndPage | 114775 |
ExternalDocumentID | oai_doaj_org_article_cd95ee50557d4814a8a39cb378017007 10.1016/j.celrep.2024.114775 PMC11511630 39305483 10_1016_j_celrep_2024_114775 S2211124724011264 |
Genre | Journal Article |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: R35 GM133404 – fundername: NCI NIH HHS grantid: U54 CA274499 – fundername: NCI NIH HHS grantid: R01 CA249229 – fundername: NCI NIH HHS grantid: P30 CA044579 – fundername: NINDS NIH HHS grantid: R21 NS125479 – fundername: NIGMS NIH HHS grantid: T32 GM145443 |
GroupedDBID | 0R~ 4.4 457 53G 5VS 6I. AAEDT AAEDW AAFTH AAIKJ AAKRW AALRI AAMRU AAXUO AAYWO ABMAC ACGFO ACGFS ADBBV ADEZE ADVLN AENEX AEXQZ AFTJW AGHFR AITUG AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP BAWUL BCNDV DIK EBS EJD FCP FDB FRP GROUPED_DOAJ GX1 IXB KQ8 M41 M48 O-L O9- OK1 ROL SSZ AAYXX ACVFH ADCNI AEUPX AFPUW AIGII AKBMS AKYEP CITATION HZ~ IPNFZ RIG CGR CUY CVF ECM EIF NPM 7X8 5PM ADTOC UNPAY |
ID | FETCH-LOGICAL-c479t-31171872133c2a1a59040545e93caedf7cdeba17c6938c1f0859db0844803f153 |
IEDL.DBID | DOA |
ISSN | 2211-1247 2639-1856 |
IngestDate | Wed Aug 27 01:21:24 EDT 2025 Tue Aug 19 09:30:31 EDT 2025 Tue Sep 30 17:07:37 EDT 2025 Fri Jul 11 03:50:50 EDT 2025 Mon Jul 21 06:06:16 EDT 2025 Wed Oct 01 08:28:22 EDT 2025 Sat May 24 17:06:17 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | multivariate modeling cancer metabolism cancer therapies mitochondrial electron transport chain metabolic state vulnerabilities CP: Metabolism CP: Cancer synthetic lethality PTEN glioma oxidative phosphorylation |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c479t-31171872133c2a1a59040545e93caedf7cdeba17c6938c1f0859db0844803f153 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 AUTHOR CONTRIBUTIONS C.A. and M.F.-S. conceived and designed the study. C.A. performed the computational modeling work. A.D.K. and Y.J. performed the experiments. A.D.K. analyzed the experimental data. C.A., A.D.K., Y.J., H.Z., and M.F.-S. wrote and edited the manuscript. M.F.-S. supervised the work. |
ORCID | 0000-0003-0917-3525 |
OpenAccessLink | https://doaj.org/article/cd95ee50557d4814a8a39cb378017007 |
PMID | 39305483 |
PQID | 3107785163 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_cd95ee50557d4814a8a39cb378017007 unpaywall_primary_10_1016_j_celrep_2024_114775 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11511630 proquest_miscellaneous_3107785163 pubmed_primary_39305483 crossref_primary_10_1016_j_celrep_2024_114775 elsevier_sciencedirect_doi_10_1016_j_celrep_2024_114775 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-10-22 |
PublicationDateYYYYMMDD | 2024-10-22 |
PublicationDate_xml | – month: 10 year: 2024 text: 2024-10-22 day: 22 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Cell reports (Cambridge) |
PublicationTitleAlternate | Cell Rep |
PublicationYear | 2024 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Fendt, Frezza, Erez (bib4) 2020; 10 Bi, Chowdhry, Wu, Zhang, Masui, Mischel (bib64) 2020; 20 Yang, Griffin, Qiang, Ren (bib19) 2022; 7 Ackermann, Tardito (bib32) 2019; 5 Mayers, Vander Heiden (bib54) 2017; 77 Jonsson, Lin, Young, DiStefano, Hyman, Li, Berger, Zehir, Ladanyi, Solit (bib44) 2019; 25 Yen, Travins, Wang, David, Artin, Straley, Padyana, Gross, DeLaBarre, Tobin (bib7) 2017; 7 Sondka, Dhir, Carvalho-Silva, Jupe, Ahmed, McLaren, Starkey, Ward, Wilding (bib34) 2024; 52 Ledur, Liu, He, Harris, Minussi, Zhou, Shaffrey, Asthagiri, Lopes, Schiff (bib50) 2016; 18 Sun, Wang, Zhou, Chen, Wang, Huang, Gao, Wang, Shu, Lu (bib67) 2023; 14 Du, Su, Qian, Yuan, Miao, Lee, Ng, Wijker, Ribas, Levine (bib53) 2020; 11 Xia, Wishart (bib30) 2011; 6 Stirling, Swain-Bowden, Lucas, Carpenter, Cimini, Goodman (bib70) 2021; 22 Nwosu, Ward, Sajjakulnukit, Poudel, Ragulan, Kasperek, Radyk, Sutton, Menjivar, Andren (bib9) 2023; 618 Joly, Chew, Graham (bib13) 2021; 17 Goldman, Craft, Hastie, Repečka, McDade, Kamath, Banerjee, Luo, Rogers, Brooks (bib28) 2020; 38 Liu, Sage, Miller, Verhaak, Hippenmeyer, Vogel, Foreman, Bronson, Nishiyama, Luo, Zong (bib71) 2011; 146 Sessions, Kim, Kashatus, Churchill, Park, Mayo, Sesaki, Kashatus (bib22) 2022; 41 Barretina, Caponigro, Stransky, Venkatesan, Margolin, Kim, Wilson, Lehár, Kryukov, Sonkin (bib23) 2012; 483 Lesche, Groszer, Gao, Wang, Messing, Sun, Liu, Wu (bib72) 2002; 32 Bayona-Bafaluy, Montoya, Ruiz-Pesini (bib33) 2021; 31 Bi, Wu, Zhang, Mischel (bib3) 2018; 1870 Leeuwenburgh, Urzúa-Traslaviña, Bhattacharya, Walvoort, Jalving, de Jong, Fehrmann (bib18) 2021; 9 Dempster, Boyle, Vazquez, Root, Boehm, Hahn, Tsherniak, McFarland (bib35) 2021; 22 Wold (bib73) 1994; 23 Mayers, Torrence, Danai, Papagiannakopoulos, Davidson, Bauer, Lau, Ji, Dixit, Hosios (bib55) 2016; 353 Molina, Sun, Protopopova, Gera, Bandi, Bristow, McAfoos, Morlacchi, Ackroyd, Agip (bib46) 2018; 24 Foretz, Guigas, Viollet (bib51) 2023; 19 Cogliati, Frezza, Soriano, Varanita, Quintana-Cabrera, Corrado, Cipolat, Costa, Casarin, Gomes (bib57) 2013; 155 Weinstein, Collisson, Mills, Shaw, Ozenberger, Ellrott, Shmulevich, Sander, Stuart (bib27) 2013; 45 Machado, Heather, Harris, Higgins (bib61) 2023; 129 Kondo, Ratcliffe, Hooper, Ellis, MacRae, Hennequart, Dunsby, Anderson, Sahai (bib5) 2021; 34 Shi, Lim, Liang, Iyer, Wang, Wang, Xie, Sun, Chen, Tabar (bib45) 2019; 567 Garofano, Migliozzi, Oh, D’Angelo, Najac, Ko, Frangaj, Caruso, Yu, Yuan (bib62) 2021; 2 Ghandi, Huang, Jané-Valbuena, Kryukov, Lo, McDonald, Barretina, Gelfand, Bielski, Li (bib12) 2019; 569 Kanehisa, Sato, Kawashima, Furumichi, Tanabe (bib25) 2016; 44 Ulanovskaya, Janjic, Suzuki, Sabharwal, Schumacker, Kron, Kozmin (bib43) 2008; 4 Becht, McInnes, Healy, Dutertre, Kwok, Ng, Ginhoux, Newell (bib24) 2018; 37 Sesen, Dahan, Scotland, Saland, Dang, Lemarié, Tyler, Brem, Toulas, Cohen-Jonathan Moyal (bib47) 2015; 10 Stine, Schug, Salvino, Dang (bib2) 2022; 21 Finley (bib1) 2023; 186 Naguib, Mathew, Reczek, Watrud, Ambrico, Herzka, Salas, Lee, El-Amine, Zheng (bib59) 2018; 23 Barthel, Johnson, Varn, Moskalik, Tanner, Kocakavuk, Anderson, Abiola, Aldape, Alfaro (bib48) 2019; 576 Kinker, Greenwald, Tal, Orlova, Cuoco, McFarland, Warren, Rodman, Roth, Bender (bib31) 2020; 52 Hu, Allam, Cai, Henderson, Yueh, Garipcan, Ievlev, Afkarian, Beyaz, Coskun (bib65) 2023; 14 Bairoch (bib68) 2018; 29 Xiao, Dai, Locasale (bib29) 2019; 10 Rees, Seashore-Ludlow, Cheah, Adams, Price, Gill, Javaid, Coletti, Jones, Bodycombe (bib41) 2016; 12 Shorthouse, Bradley, Critchlow, Bendtsen, Hall (bib16) 2022; 18 Behan, Iorio, Picco, Gonçalves, Beaver, Migliardi, Santos, Rao, Sassi, Pinnelli (bib36) 2019; 568 Sighel, Notarangelo, Aibara, Re, Ricci, Guida, Soldano, Adami, Ambrosini, Broso (bib63) 2021; 35 Gwynne, Suk, Custers, Mikolajewicz, Chan, Zador, Chafe, Zhai, Escudero, Zhang (bib10) 2022; 40 Yap, Daver, Mahendra, Zhang, Kamiya-Matsuoka, Meric-Bernstam, Kantarjian, Ravandi, Collins, Francesco (bib60) 2023; 29 Selva, van de Sandt, Lemke, Lee, Shoffner, Chua, Davis, Nguyen, Rowntree, Hensen (bib38) 2021; 12 Cherkaoui, Durot, Bradley, Critchlow, Dubuis, Masiero, Wegmann, Snijder, Othman, Bendtsen, Zamboni (bib15) 2022; 18 Cerami, Gao, Dogrusoz, Gross, Sumer, Aksoy, Jacobsen, Byrne, Heuer, Larsson (bib74) 2012; 2 Li, Ning, Ghandi, Kryukov, Gopal, Deik, Souza, Pierce, Keskula, Hernandez (bib11) 2019; 25 Pemovska, Bigenzahn, Srndic, Lercher, Bergthaler, César-Razquin, Kartnig, Kornauth, Valent, Staber, Superti-Furga (bib17) 2021; 12 Anderson, Wardell, Cakir, Yip, Ahn, Ali, Yllanes, Chao, McDonnell, Wood (bib58) 2018; 9 Warren, Chen, Jones, Shibue, Hahn, Boehm, Vazquez, Tsherniak, McFarland (bib26) 2021; 12 Zhang, Cao, Dong, Lin (bib39) 2020; 117 Han, Bushong, Segawa, Tiard, Wong, Brady, Momcilovic, Wolf, Zhang, Petcherski (bib56) 2023; 615 Abecunas, Whitehead, Ziemke, Baumann, Frankowski-McGregor, Sebolt-Leopold, Fallahi-Sichani (bib75) 2023; 83 Campit, Bhowmick, Lu, Saoji, Jin, Robida, Chandrasekaran (bib21) 2023 Gunn, Yu, Karim, Brannan, Herbert, Wec, Halfmann, Fusco, Schendel, Gangavarapu (bib37) 2018; 24 Kuleshov, Jones, Rouillard, Fernandez, Duan, Wang, Koplev, Jenkins, Jagodnik, Lachmann (bib69) 2016; 44 Kim, Hu, Cai, Li, Choi, Faubert, Bezwada, Rodriguez-Canales, Villalobos, Lin (bib8) 2017; 546 Ruiz-Moreno, Salas, Samuelsson, Brandner, Kranendonk, Nilsson, Stunnenberg (bib49) 2022 Maan, Baghel, Dhariwal, Sharma, Bakhshi, Rana (bib66) 2023; 9 Mendiratta, Ke, Aziz, Liarakos, Tong, Stites (bib40) 2021; 12 Lagziel, Lee, Shlomi (bib14) 2019; 17 Linnett, Beechey (bib42) 1979 Rohle, Popovici-Muller, Palaskas, Turcan, Grommes, Campos, Tsoi, Clark, Oldrini, Komisopoulou (bib6) 2013; 340 Benedetti, Liu, Tang, Kuo, Buyukozkan, Park, Park, Correa, Hakimi, Intlekofer (bib20) 2023; 5 Mahendralingam, Kim, McCloskey, Aliar, Casey, Tharmapalan, Pellacani, Ignatchenko, Garcia-Valero, Palomero (bib52) 2021; 3 Shi (10.1016/j.celrep.2024.114775_bib45) 2019; 567 Molina (10.1016/j.celrep.2024.114775_bib46) 2018; 24 Mendiratta (10.1016/j.celrep.2024.114775_bib40) 2021; 12 Lagziel (10.1016/j.celrep.2024.114775_bib14) 2019; 17 Cerami (10.1016/j.celrep.2024.114775_bib74) 2012; 2 Ghandi (10.1016/j.celrep.2024.114775_bib12) 2019; 569 Ledur (10.1016/j.celrep.2024.114775_bib50) 2016; 18 Fendt (10.1016/j.celrep.2024.114775_bib4) 2020; 10 Warren (10.1016/j.celrep.2024.114775_bib26) 2021; 12 Barthel (10.1016/j.celrep.2024.114775_bib48) 2019; 576 Foretz (10.1016/j.celrep.2024.114775_bib51) 2023; 19 Naguib (10.1016/j.celrep.2024.114775_bib59) 2018; 23 Ackermann (10.1016/j.celrep.2024.114775_bib32) 2019; 5 Maan (10.1016/j.celrep.2024.114775_bib66) 2023; 9 Sondka (10.1016/j.celrep.2024.114775_bib34) 2024; 52 Joly (10.1016/j.celrep.2024.114775_bib13) 2021; 17 Barretina (10.1016/j.celrep.2024.114775_bib23) 2012; 483 Sesen (10.1016/j.celrep.2024.114775_bib47) 2015; 10 Mayers (10.1016/j.celrep.2024.114775_bib54) 2017; 77 Lesche (10.1016/j.celrep.2024.114775_bib72) 2002; 32 Becht (10.1016/j.celrep.2024.114775_bib24) 2018; 37 Garofano (10.1016/j.celrep.2024.114775_bib62) 2021; 2 Pemovska (10.1016/j.celrep.2024.114775_bib17) 2021; 12 Rees (10.1016/j.celrep.2024.114775_bib41) 2016; 12 Gunn (10.1016/j.celrep.2024.114775_bib37) 2018; 24 Sighel (10.1016/j.celrep.2024.114775_bib63) 2021; 35 Weinstein (10.1016/j.celrep.2024.114775_bib27) 2013; 45 Kanehisa (10.1016/j.celrep.2024.114775_bib25) 2016; 44 Mahendralingam (10.1016/j.celrep.2024.114775_bib52) 2021; 3 Rohle (10.1016/j.celrep.2024.114775_bib6) 2013; 340 Abecunas (10.1016/j.celrep.2024.114775_bib75) 2023; 83 Xiao (10.1016/j.celrep.2024.114775_bib29) 2019; 10 Leeuwenburgh (10.1016/j.celrep.2024.114775_bib18) 2021; 9 Campit (10.1016/j.celrep.2024.114775_bib21) 2023 Ulanovskaya (10.1016/j.celrep.2024.114775_bib43) 2008; 4 Selva (10.1016/j.celrep.2024.114775_bib38) 2021; 12 Du (10.1016/j.celrep.2024.114775_bib53) 2020; 11 Cherkaoui (10.1016/j.celrep.2024.114775_bib15) 2022; 18 Zhang (10.1016/j.celrep.2024.114775_bib39) 2020; 117 Anderson (10.1016/j.celrep.2024.114775_bib58) 2018; 9 Dempster (10.1016/j.celrep.2024.114775_bib35) 2021; 22 Machado (10.1016/j.celrep.2024.114775_bib61) 2023; 129 Ruiz-Moreno (10.1016/j.celrep.2024.114775_bib49) 2022 Sessions (10.1016/j.celrep.2024.114775_bib22) 2022; 41 Wold (10.1016/j.celrep.2024.114775_bib73) 1994; 23 Shorthouse (10.1016/j.celrep.2024.114775_bib16) 2022; 18 Kinker (10.1016/j.celrep.2024.114775_bib31) 2020; 52 Yap (10.1016/j.celrep.2024.114775_bib60) 2023; 29 Jonsson (10.1016/j.celrep.2024.114775_bib44) 2019; 25 Cogliati (10.1016/j.celrep.2024.114775_bib57) 2013; 155 Kondo (10.1016/j.celrep.2024.114775_bib5) 2021; 34 Nwosu (10.1016/j.celrep.2024.114775_bib9) 2023; 618 Bi (10.1016/j.celrep.2024.114775_bib3) 2018; 1870 Kim (10.1016/j.celrep.2024.114775_bib8) 2017; 546 Kuleshov (10.1016/j.celrep.2024.114775_bib69) 2016; 44 Linnett (10.1016/j.celrep.2024.114775_bib42) 1979 Goldman (10.1016/j.celrep.2024.114775_bib28) 2020; 38 Yang (10.1016/j.celrep.2024.114775_bib19) 2022; 7 Han (10.1016/j.celrep.2024.114775_bib56) 2023; 615 Gwynne (10.1016/j.celrep.2024.114775_bib10) 2022; 40 Stine (10.1016/j.celrep.2024.114775_bib2) 2022; 21 Li (10.1016/j.celrep.2024.114775_bib11) 2019; 25 Benedetti (10.1016/j.celrep.2024.114775_bib20) 2023; 5 Sun (10.1016/j.celrep.2024.114775_bib67) 2023; 14 Behan (10.1016/j.celrep.2024.114775_bib36) 2019; 568 Yen (10.1016/j.celrep.2024.114775_bib7) 2017; 7 Mayers (10.1016/j.celrep.2024.114775_bib55) 2016; 353 Liu (10.1016/j.celrep.2024.114775_bib71) 2011; 146 Finley (10.1016/j.celrep.2024.114775_bib1) 2023; 186 Stirling (10.1016/j.celrep.2024.114775_bib70) 2021; 22 Xia (10.1016/j.celrep.2024.114775_bib30) 2011; 6 Bayona-Bafaluy (10.1016/j.celrep.2024.114775_bib33) 2021; 31 Hu (10.1016/j.celrep.2024.114775_bib65) 2023; 14 Bairoch (10.1016/j.celrep.2024.114775_bib68) 2018; 29 Bi (10.1016/j.celrep.2024.114775_bib64) 2020; 20 38076921 - bioRxiv. 2024 Jul 10:2023.11.28.569098. doi: 10.1101/2023.11.28.569098 |
References_xml | – volume: 353 start-page: 1161 year: 2016 end-page: 1165 ident: bib55 article-title: Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers publication-title: Science – volume: 20 start-page: 57 year: 2020 end-page: 70 ident: bib64 article-title: Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets publication-title: Nat. Rev. Cancer – volume: 10 year: 2015 ident: bib47 article-title: Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response publication-title: PLoS One – volume: 38 start-page: 675 year: 2020 end-page: 678 ident: bib28 article-title: Visualizing and interpreting cancer genomics data via the Xena platform publication-title: Nat. Biotechnol. – year: 2022 ident: bib49 article-title: Harmonized single-cell landscape, intercellular crosstalk and tumor architecture of glioblastoma publication-title: bioRxiv – volume: 12 start-page: 5961 year: 2021 ident: bib40 article-title: Cancer gene mutation frequencies for the U.S. population publication-title: Nat. Commun. – volume: 4 start-page: 418 year: 2008 end-page: 424 ident: bib43 article-title: Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide publication-title: Nat. Chem. Biol. – volume: 1870 start-page: 76 year: 2018 end-page: 87 ident: bib3 article-title: Targeting cancer’s metabolic co-dependencies: A landscape shaped by genotype and tissue context publication-title: Biochim. Biophys. Acta Rev. Canc – volume: 23 start-page: 149 year: 1994 end-page: 161 ident: bib73 article-title: Exponentially weighted moving principal components analysis and projections to latent structures publication-title: Chemometr. Intell. Lab. Syst. – volume: 18 start-page: 1413 year: 2016 end-page: 1424 ident: bib50 article-title: Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells publication-title: Neuro Oncol. – volume: 44 start-page: W90 year: 2016 end-page: W97 ident: bib69 article-title: Enrichr: a comprehensive gene set enrichment analysis web server 2016 update publication-title: Nucleic Acids Res. – volume: 22 start-page: 433 year: 2021 ident: bib70 article-title: CellProfiler 4: improvements in speed, utility and usability publication-title: BMC Bioinf. – volume: 576 start-page: 112 year: 2019 end-page: 120 ident: bib48 article-title: Longitudinal molecular trajectories of diffuse glioma in adults publication-title: Nature – year: 2023 ident: bib21 article-title: Data-Driven Screening to Infer Metabolic Modulators of the Cancer Epigenome publication-title: bioRxiv – volume: 45 start-page: 1113 year: 2013 end-page: 1120 ident: bib27 article-title: The Cancer Genome Atlas Pan-Cancer analysis project publication-title: Nat. Genet. – volume: 11 start-page: 4830 year: 2020 ident: bib53 article-title: Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells publication-title: Nat. Commun. – volume: 29 start-page: 115 year: 2023 end-page: 126 ident: bib60 article-title: Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials publication-title: Nat. Med. – volume: 24 start-page: 221 year: 2018 end-page: 233.e5 ident: bib37 article-title: A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus publication-title: Cell Host Microbe – volume: 14 start-page: 8260 year: 2023 ident: bib65 article-title: Single-cell spatial metabolomics with cell-type specific protein profiling for tissue systems biology publication-title: Nat. Commun. – volume: 32 start-page: 148 year: 2002 end-page: 149 ident: bib72 article-title: Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene publication-title: Genesis – volume: 9 start-page: 1677 year: 2018 ident: bib58 article-title: Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors publication-title: Nat. Commun. – volume: 340 start-page: 626 year: 2013 end-page: 630 ident: bib6 article-title: An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells publication-title: Science – volume: 3 start-page: 665 year: 2021 end-page: 681 ident: bib52 article-title: Mammary epithelial cells have lineage-rooted metabolic identities publication-title: Nat. Metab. – volume: 25 start-page: 850 year: 2019 end-page: 860 ident: bib11 article-title: The landscape of cancer cell line metabolism publication-title: Nat. Med. – volume: 5 start-page: 329 year: 2019 end-page: 332 ident: bib32 article-title: Cell Culture Medium Formulation and Its Implications in Cancer Metabolism publication-title: Trends Cancer – volume: 22 start-page: 343 year: 2021 ident: bib35 article-title: Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects publication-title: Genome Biol. – volume: 12 start-page: 22 year: 2021 ident: bib26 article-title: Global computational alignment of tumor and cell line transcriptional profiles publication-title: Nat. Commun. – volume: 618 start-page: 151 year: 2023 end-page: 158 ident: bib9 article-title: Uridine-derived ribose fuels glucose-restricted pancreatic cancer publication-title: Nature – volume: 2 start-page: 401 year: 2012 end-page: 404 ident: bib74 article-title: The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data publication-title: Cancer Discov. – volume: 615 start-page: 712 year: 2023 end-page: 719 ident: bib56 article-title: Spatial mapping of mitochondrial networks and bioenergetics in lung cancer publication-title: Nature – volume: 77 start-page: 3131 year: 2017 end-page: 3134 ident: bib54 article-title: Nature and Nurture: What Determines Tumor Metabolic Phenotypes? publication-title: Cancer Res. – volume: 186 start-page: 1670 year: 2023 end-page: 1688 ident: bib1 article-title: What is cancer metabolism? publication-title: Cell – volume: 83 start-page: 316 year: 2023 end-page: 331 ident: bib75 article-title: Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition publication-title: Cancer Res. – volume: 25 start-page: 5537 year: 2019 end-page: 5547 ident: bib44 article-title: Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas publication-title: Clin. Cancer Res. – volume: 483 start-page: 603 year: 2012 end-page: 607 ident: bib23 article-title: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity publication-title: Nature – volume: 10 start-page: 1797 year: 2020 end-page: 1807 ident: bib4 article-title: Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy publication-title: Cancer Discov. – volume: 29 start-page: 25 year: 2018 end-page: 38 ident: bib68 article-title: The Cellosaurus, a Cell-Line Knowledge Resource publication-title: J. Biomol. Tech. – volume: 52 start-page: D1210 year: 2024 end-page: D1217 ident: bib34 article-title: COSMIC: a curated database of somatic variants and clinical data for cancer publication-title: Nucleic Acids Res. – start-page: 472 year: 1979 end-page: 518 ident: bib42 article-title: Inhibitors of the ATP synthetase systems publication-title: Methods in Enzymology – volume: 34 year: 2021 ident: bib5 article-title: Single-cell resolved imaging reveals intra-tumor heterogeneity in glycolysis, transitions between metabolic states, and their regulatory mechanisms publication-title: Cell Rep. – volume: 7 start-page: 379 year: 2022 ident: bib19 article-title: Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology publication-title: Signal Transduct. Targeted Ther. – volume: 18 year: 2022 ident: bib16 article-title: Heterogeneity of the cancer cell line metabolic landscape publication-title: Mol. Syst. Biol. – volume: 41 year: 2022 ident: bib22 article-title: Opa1 and Drp1 reciprocally regulate cristae morphology, ETC function, and NAD+ regeneration in KRas-mutant lung adenocarcinoma publication-title: Cell Rep. – volume: 12 start-page: 2037 year: 2021 ident: bib38 article-title: Systems serology detects functionally distinct coronavirus antibody features in children and elderly publication-title: Nat. Commun. – volume: 23 start-page: 58 year: 2018 end-page: 67 ident: bib59 article-title: Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells publication-title: Cell Rep. – volume: 35 year: 2021 ident: bib63 article-title: Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth publication-title: Cell Rep. – volume: 52 start-page: 1208 year: 2020 end-page: 1218 ident: bib31 article-title: Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity publication-title: Nat. Genet. – volume: 6 start-page: 743 year: 2011 end-page: 760 ident: bib30 article-title: Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst publication-title: Nat. Protoc. – volume: 14 start-page: 2692 year: 2023 ident: bib67 article-title: Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer publication-title: Nat. Commun. – volume: 12 start-page: 7190 year: 2021 ident: bib17 article-title: Metabolic drug survey highlights cancer cell dependencies and vulnerabilities publication-title: Nat. Commun. – volume: 546 start-page: 168 year: 2017 end-page: 172 ident: bib8 article-title: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells publication-title: Nature – volume: 146 start-page: 209 year: 2011 end-page: 221 ident: bib71 article-title: Mosaic analysis with double markers reveals tumor cell of origin in glioma publication-title: Cell – volume: 7 start-page: 478 year: 2017 end-page: 493 ident: bib7 article-title: AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations publication-title: Cancer Discov. – volume: 19 start-page: 460 year: 2023 end-page: 476 ident: bib51 article-title: Metformin: update on mechanisms of action and repurposing potential publication-title: Nat. Rev. Endocrinol. – volume: 44 start-page: D457 year: 2016 end-page: D462 ident: bib25 article-title: KEGG as a reference resource for gene and protein annotation publication-title: Nucleic Acids Res. – volume: 568 start-page: 511 year: 2019 end-page: 516 ident: bib36 article-title: Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens publication-title: Nature – volume: 2 start-page: 141 year: 2021 end-page: 156 ident: bib62 article-title: Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities publication-title: Nat. Can. (Ott.) – volume: 12 start-page: 109 year: 2016 end-page: 116 ident: bib41 article-title: Correlating chemical sensitivity and basal gene expression reveals mechanism of action publication-title: Nat. Chem. Biol. – volume: 567 start-page: 341 year: 2019 end-page: 346 ident: bib45 article-title: Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma publication-title: Nature – volume: 17 year: 2021 ident: bib13 article-title: The landscape of metabolic pathway dependencies in cancer cell lines publication-title: PLoS Comput. Biol. – volume: 9 start-page: 35 year: 2021 ident: bib18 article-title: Robust metabolic transcriptional components in 34,494 patient-derived cancer-related samples and cell lines publication-title: Cancer Metabol. – volume: 31 start-page: 618 year: 2021 end-page: 620 ident: bib33 article-title: Oxidative phosphorylation system and cell culture media publication-title: Trends Cell Biol. – volume: 155 start-page: 160 year: 2013 end-page: 171 ident: bib57 article-title: Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency publication-title: Cell – volume: 9 start-page: 42 year: 2023 ident: bib66 article-title: Metabolomics and transcriptomics based multi-omics integration reveals radiation-induced altered pathway networking and underlying mechanism publication-title: NPJ Syst. Biol. Appl. – volume: 37 start-page: 38 year: 2018 end-page: 44 ident: bib24 article-title: Dimensionality reduction for visualizing single-cell data using UMAP publication-title: Nat. Biotechnol. – volume: 10 start-page: 3763 year: 2019 ident: bib29 article-title: Metabolic landscape of the tumor microenvironment at single cell resolution publication-title: Nat. Commun. – volume: 24 start-page: 1036 year: 2018 end-page: 1046 ident: bib46 article-title: An inhibitor of oxidative phosphorylation exploits cancer vulnerability publication-title: Nat. Med. – volume: 21 start-page: 141 year: 2022 end-page: 162 ident: bib2 article-title: Targeting cancer metabolism in the era of precision oncology publication-title: Nat. Rev. Drug Discov. – volume: 40 start-page: 1488 year: 2022 end-page: 1502.e7 ident: bib10 article-title: Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma publication-title: Cancer Cell – volume: 569 start-page: 503 year: 2019 end-page: 508 ident: bib12 article-title: Next-generation characterization of the Cancer Cell Line Encyclopedia publication-title: Nature – volume: 5 start-page: 1029 year: 2023 end-page: 1044 ident: bib20 article-title: A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariation publication-title: Nat. Metab. – volume: 18 year: 2022 ident: bib15 article-title: A functional analysis of 180 cancer cell lines reveals conserved intrinsic metabolic programs publication-title: Mol. Syst. Biol. – volume: 17 start-page: 37 year: 2019 ident: bib14 article-title: Inferring cancer dependencies on metabolic genes from large-scale genetic screens publication-title: BMC Biol. – volume: 117 start-page: 13447 year: 2020 end-page: 13456 ident: bib39 article-title: TiPARP forms nuclear condensates to degrade HIF-1α and suppress tumorigenesis publication-title: Proc. Natl. Acad. Sci. USA – volume: 129 start-page: 897 year: 2023 end-page: 899 ident: bib61 article-title: Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities publication-title: Br. J. Cancer – volume: 22 start-page: 343 year: 2021 ident: 10.1016/j.celrep.2024.114775_bib35 article-title: Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects publication-title: Genome Biol. doi: 10.1186/s13059-021-02540-7 – volume: 23 start-page: 149 year: 1994 ident: 10.1016/j.celrep.2024.114775_bib73 article-title: Exponentially weighted moving principal components analysis and projections to latent structures publication-title: Chemometr. Intell. Lab. Syst. doi: 10.1016/0169-7439(93)E0075-F – volume: 12 start-page: 109 year: 2016 ident: 10.1016/j.celrep.2024.114775_bib41 article-title: Correlating chemical sensitivity and basal gene expression reveals mechanism of action publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.1986 – volume: 52 start-page: D1210 year: 2024 ident: 10.1016/j.celrep.2024.114775_bib34 article-title: COSMIC: a curated database of somatic variants and clinical data for cancer publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkad986 – volume: 10 start-page: 1797 year: 2020 ident: 10.1016/j.celrep.2024.114775_bib4 article-title: Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-20-0844 – volume: 29 start-page: 25 year: 2018 ident: 10.1016/j.celrep.2024.114775_bib68 article-title: The Cellosaurus, a Cell-Line Knowledge Resource publication-title: J. Biomol. Tech. doi: 10.7171/jbt.18-2902-002 – volume: 5 start-page: 329 year: 2019 ident: 10.1016/j.celrep.2024.114775_bib32 article-title: Cell Culture Medium Formulation and Its Implications in Cancer Metabolism publication-title: Trends Cancer doi: 10.1016/j.trecan.2019.05.004 – volume: 3 start-page: 665 year: 2021 ident: 10.1016/j.celrep.2024.114775_bib52 article-title: Mammary epithelial cells have lineage-rooted metabolic identities publication-title: Nat. Metab. doi: 10.1038/s42255-021-00388-6 – volume: 83 start-page: 316 year: 2023 ident: 10.1016/j.celrep.2024.114775_bib75 article-title: Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-22-0883 – volume: 44 start-page: D457 year: 2016 ident: 10.1016/j.celrep.2024.114775_bib25 article-title: KEGG as a reference resource for gene and protein annotation publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkv1070 – volume: 34 year: 2021 ident: 10.1016/j.celrep.2024.114775_bib5 article-title: Single-cell resolved imaging reveals intra-tumor heterogeneity in glycolysis, transitions between metabolic states, and their regulatory mechanisms publication-title: Cell Rep. doi: 10.1016/j.celrep.2021.108750 – volume: 35 year: 2021 ident: 10.1016/j.celrep.2024.114775_bib63 article-title: Inhibition of mitochondrial translation suppresses glioblastoma stem cell growth publication-title: Cell Rep. doi: 10.1016/j.celrep.2021.109024 – volume: 10 year: 2015 ident: 10.1016/j.celrep.2024.114775_bib47 article-title: Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response publication-title: PLoS One doi: 10.1371/journal.pone.0123721 – volume: 155 start-page: 160 year: 2013 ident: 10.1016/j.celrep.2024.114775_bib57 article-title: Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency publication-title: Cell doi: 10.1016/j.cell.2013.08.032 – volume: 17 start-page: 37 year: 2019 ident: 10.1016/j.celrep.2024.114775_bib14 article-title: Inferring cancer dependencies on metabolic genes from large-scale genetic screens publication-title: BMC Biol. doi: 10.1186/s12915-019-0654-4 – volume: 567 start-page: 341 year: 2019 ident: 10.1016/j.celrep.2024.114775_bib45 article-title: Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma publication-title: Nature doi: 10.1038/s41586-019-0993-x – volume: 38 start-page: 675 year: 2020 ident: 10.1016/j.celrep.2024.114775_bib28 article-title: Visualizing and interpreting cancer genomics data via the Xena platform publication-title: Nat. Biotechnol. doi: 10.1038/s41587-020-0546-8 – volume: 41 year: 2022 ident: 10.1016/j.celrep.2024.114775_bib22 article-title: Opa1 and Drp1 reciprocally regulate cristae morphology, ETC function, and NAD+ regeneration in KRas-mutant lung adenocarcinoma publication-title: Cell Rep. doi: 10.1016/j.celrep.2022.111818 – volume: 25 start-page: 5537 year: 2019 ident: 10.1016/j.celrep.2024.114775_bib44 article-title: Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-19-0032 – volume: 2 start-page: 401 year: 2012 ident: 10.1016/j.celrep.2024.114775_bib74 article-title: The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-12-0095 – volume: 2 start-page: 141 year: 2021 ident: 10.1016/j.celrep.2024.114775_bib62 article-title: Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities publication-title: Nat. Can. (Ott.) doi: 10.1038/s43018-020-00159-4 – volume: 29 start-page: 115 year: 2023 ident: 10.1016/j.celrep.2024.114775_bib60 article-title: Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials publication-title: Nat. Med. doi: 10.1038/s41591-022-02103-8 – volume: 25 start-page: 850 year: 2019 ident: 10.1016/j.celrep.2024.114775_bib11 article-title: The landscape of cancer cell line metabolism publication-title: Nat. Med. doi: 10.1038/s41591-019-0404-8 – volume: 12 start-page: 5961 year: 2021 ident: 10.1016/j.celrep.2024.114775_bib40 article-title: Cancer gene mutation frequencies for the U.S. population publication-title: Nat. Commun. doi: 10.1038/s41467-021-26213-y – volume: 568 start-page: 511 year: 2019 ident: 10.1016/j.celrep.2024.114775_bib36 article-title: Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens publication-title: Nature doi: 10.1038/s41586-019-1103-9 – volume: 615 start-page: 712 year: 2023 ident: 10.1016/j.celrep.2024.114775_bib56 article-title: Spatial mapping of mitochondrial networks and bioenergetics in lung cancer publication-title: Nature doi: 10.1038/s41586-023-05793-3 – volume: 12 start-page: 7190 year: 2021 ident: 10.1016/j.celrep.2024.114775_bib17 article-title: Metabolic drug survey highlights cancer cell dependencies and vulnerabilities publication-title: Nat. Commun. doi: 10.1038/s41467-021-27329-x – volume: 9 start-page: 1677 year: 2018 ident: 10.1016/j.celrep.2024.114775_bib58 article-title: Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors publication-title: Nat. Commun. doi: 10.1038/s41467-018-04033-x – volume: 12 start-page: 2037 year: 2021 ident: 10.1016/j.celrep.2024.114775_bib38 article-title: Systems serology detects functionally distinct coronavirus antibody features in children and elderly publication-title: Nat. Commun. doi: 10.1038/s41467-021-22236-7 – year: 2023 ident: 10.1016/j.celrep.2024.114775_bib21 article-title: Data-Driven Screening to Infer Metabolic Modulators of the Cancer Epigenome publication-title: bioRxiv – volume: 22 start-page: 433 year: 2021 ident: 10.1016/j.celrep.2024.114775_bib70 article-title: CellProfiler 4: improvements in speed, utility and usability publication-title: BMC Bioinf. doi: 10.1186/s12859-021-04344-9 – volume: 1870 start-page: 76 year: 2018 ident: 10.1016/j.celrep.2024.114775_bib3 article-title: Targeting cancer’s metabolic co-dependencies: A landscape shaped by genotype and tissue context publication-title: Biochim. Biophys. Acta Rev. Canc doi: 10.1016/j.bbcan.2018.05.002 – volume: 31 start-page: 618 year: 2021 ident: 10.1016/j.celrep.2024.114775_bib33 article-title: Oxidative phosphorylation system and cell culture media publication-title: Trends Cell Biol. doi: 10.1016/j.tcb.2021.05.003 – volume: 340 start-page: 626 year: 2013 ident: 10.1016/j.celrep.2024.114775_bib6 article-title: An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells publication-title: Science doi: 10.1126/science.1236062 – volume: 7 start-page: 478 year: 2017 ident: 10.1016/j.celrep.2024.114775_bib7 article-title: AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-16-1034 – volume: 19 start-page: 460 year: 2023 ident: 10.1016/j.celrep.2024.114775_bib51 article-title: Metformin: update on mechanisms of action and repurposing potential publication-title: Nat. Rev. Endocrinol. doi: 10.1038/s41574-023-00833-4 – volume: 20 start-page: 57 year: 2020 ident: 10.1016/j.celrep.2024.114775_bib64 article-title: Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-019-0226-5 – volume: 12 start-page: 22 year: 2021 ident: 10.1016/j.celrep.2024.114775_bib26 article-title: Global computational alignment of tumor and cell line transcriptional profiles publication-title: Nat. Commun. doi: 10.1038/s41467-020-20294-x – volume: 77 start-page: 3131 year: 2017 ident: 10.1016/j.celrep.2024.114775_bib54 article-title: Nature and Nurture: What Determines Tumor Metabolic Phenotypes? publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-17-0165 – volume: 24 start-page: 1036 year: 2018 ident: 10.1016/j.celrep.2024.114775_bib46 article-title: An inhibitor of oxidative phosphorylation exploits cancer vulnerability publication-title: Nat. Med. doi: 10.1038/s41591-018-0052-4 – volume: 18 start-page: 1413 year: 2016 ident: 10.1016/j.celrep.2024.114775_bib50 article-title: Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells publication-title: Neuro Oncol. doi: 10.1093/neuonc/now062 – volume: 353 start-page: 1161 year: 2016 ident: 10.1016/j.celrep.2024.114775_bib55 article-title: Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers publication-title: Science doi: 10.1126/science.aaf5171 – volume: 483 start-page: 603 year: 2012 ident: 10.1016/j.celrep.2024.114775_bib23 article-title: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity publication-title: Nature doi: 10.1038/nature11003 – volume: 5 start-page: 1029 year: 2023 ident: 10.1016/j.celrep.2024.114775_bib20 article-title: A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariation publication-title: Nat. Metab. doi: 10.1038/s42255-023-00817-8 – volume: 44 start-page: W90 year: 2016 ident: 10.1016/j.celrep.2024.114775_bib69 article-title: Enrichr: a comprehensive gene set enrichment analysis web server 2016 update publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkw377 – year: 2022 ident: 10.1016/j.celrep.2024.114775_bib49 article-title: Harmonized single-cell landscape, intercellular crosstalk and tumor architecture of glioblastoma publication-title: bioRxiv – volume: 32 start-page: 148 year: 2002 ident: 10.1016/j.celrep.2024.114775_bib72 article-title: Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene publication-title: Genesis doi: 10.1002/gene.10036 – volume: 117 start-page: 13447 year: 2020 ident: 10.1016/j.celrep.2024.114775_bib39 article-title: TiPARP forms nuclear condensates to degrade HIF-1α and suppress tumorigenesis publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.1921815117 – volume: 18 year: 2022 ident: 10.1016/j.celrep.2024.114775_bib15 article-title: A functional analysis of 180 cancer cell lines reveals conserved intrinsic metabolic programs publication-title: Mol. Syst. Biol. doi: 10.15252/msb.202211033 – volume: 6 start-page: 743 year: 2011 ident: 10.1016/j.celrep.2024.114775_bib30 article-title: Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst publication-title: Nat. Protoc. doi: 10.1038/nprot.2011.319 – volume: 21 start-page: 141 year: 2022 ident: 10.1016/j.celrep.2024.114775_bib2 article-title: Targeting cancer metabolism in the era of precision oncology publication-title: Nat. Rev. Drug Discov. doi: 10.1038/s41573-021-00339-6 – volume: 9 start-page: 42 year: 2023 ident: 10.1016/j.celrep.2024.114775_bib66 article-title: Metabolomics and transcriptomics based multi-omics integration reveals radiation-induced altered pathway networking and underlying mechanism publication-title: NPJ Syst. Biol. Appl. doi: 10.1038/s41540-023-00305-5 – volume: 569 start-page: 503 year: 2019 ident: 10.1016/j.celrep.2024.114775_bib12 article-title: Next-generation characterization of the Cancer Cell Line Encyclopedia publication-title: Nature doi: 10.1038/s41586-019-1186-3 – volume: 40 start-page: 1488 year: 2022 ident: 10.1016/j.celrep.2024.114775_bib10 article-title: Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma publication-title: Cancer Cell doi: 10.1016/j.ccell.2022.10.009 – volume: 10 start-page: 3763 year: 2019 ident: 10.1016/j.celrep.2024.114775_bib29 article-title: Metabolic landscape of the tumor microenvironment at single cell resolution publication-title: Nat. Commun. doi: 10.1038/s41467-019-11738-0 – volume: 14 start-page: 2692 year: 2023 ident: 10.1016/j.celrep.2024.114775_bib67 article-title: Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer publication-title: Nat. Commun. doi: 10.1038/s41467-023-38360-5 – volume: 4 start-page: 418 year: 2008 ident: 10.1016/j.celrep.2024.114775_bib43 article-title: Synthesis enables identification of the cellular target of leucascandrolide A and neopeltolide publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.94 – volume: 17 year: 2021 ident: 10.1016/j.celrep.2024.114775_bib13 article-title: The landscape of metabolic pathway dependencies in cancer cell lines publication-title: PLoS Comput. Biol. doi: 10.1371/journal.pcbi.1008942 – volume: 9 start-page: 35 year: 2021 ident: 10.1016/j.celrep.2024.114775_bib18 article-title: Robust metabolic transcriptional components in 34,494 patient-derived cancer-related samples and cell lines publication-title: Cancer Metabol. doi: 10.1186/s40170-021-00272-7 – volume: 45 start-page: 1113 year: 2013 ident: 10.1016/j.celrep.2024.114775_bib27 article-title: The Cancer Genome Atlas Pan-Cancer analysis project publication-title: Nat. Genet. doi: 10.1038/ng.2764 – volume: 576 start-page: 112 year: 2019 ident: 10.1016/j.celrep.2024.114775_bib48 article-title: Longitudinal molecular trajectories of diffuse glioma in adults publication-title: Nature doi: 10.1038/s41586-019-1775-1 – volume: 186 start-page: 1670 year: 2023 ident: 10.1016/j.celrep.2024.114775_bib1 article-title: What is cancer metabolism? publication-title: Cell doi: 10.1016/j.cell.2023.01.038 – volume: 618 start-page: 151 year: 2023 ident: 10.1016/j.celrep.2024.114775_bib9 article-title: Uridine-derived ribose fuels glucose-restricted pancreatic cancer publication-title: Nature doi: 10.1038/s41586-023-06073-w – volume: 7 start-page: 379 year: 2022 ident: 10.1016/j.celrep.2024.114775_bib19 article-title: Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology publication-title: Signal Transduct. Targeted Ther. doi: 10.1038/s41392-022-01243-0 – volume: 546 start-page: 168 year: 2017 ident: 10.1016/j.celrep.2024.114775_bib8 article-title: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells publication-title: Nature doi: 10.1038/nature22359 – volume: 146 start-page: 209 year: 2011 ident: 10.1016/j.celrep.2024.114775_bib71 article-title: Mosaic analysis with double markers reveals tumor cell of origin in glioma publication-title: Cell doi: 10.1016/j.cell.2011.06.014 – start-page: 472 year: 1979 ident: 10.1016/j.celrep.2024.114775_bib42 article-title: Inhibitors of the ATP synthetase systems doi: 10.1016/0076-6879(79)55061-7 – volume: 37 start-page: 38 year: 2018 ident: 10.1016/j.celrep.2024.114775_bib24 article-title: Dimensionality reduction for visualizing single-cell data using UMAP publication-title: Nat. Biotechnol. doi: 10.1038/nbt.4314 – volume: 24 start-page: 221 year: 2018 ident: 10.1016/j.celrep.2024.114775_bib37 article-title: A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus publication-title: Cell Host Microbe doi: 10.1016/j.chom.2018.07.009 – volume: 52 start-page: 1208 year: 2020 ident: 10.1016/j.celrep.2024.114775_bib31 article-title: Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity publication-title: Nat. Genet. doi: 10.1038/s41588-020-00726-6 – volume: 18 year: 2022 ident: 10.1016/j.celrep.2024.114775_bib16 article-title: Heterogeneity of the cancer cell line metabolic landscape publication-title: Mol. Syst. Biol. doi: 10.15252/msb.202211006 – volume: 129 start-page: 897 year: 2023 ident: 10.1016/j.celrep.2024.114775_bib61 article-title: Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities publication-title: Br. J. Cancer doi: 10.1038/s41416-023-02394-9 – volume: 14 start-page: 8260 year: 2023 ident: 10.1016/j.celrep.2024.114775_bib65 article-title: Single-cell spatial metabolomics with cell-type specific protein profiling for tissue systems biology publication-title: Nat. Commun. doi: 10.1038/s41467-023-43917-5 – volume: 23 start-page: 58 year: 2018 ident: 10.1016/j.celrep.2024.114775_bib59 article-title: Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells publication-title: Cell Rep. doi: 10.1016/j.celrep.2018.03.032 – volume: 11 start-page: 4830 year: 2020 ident: 10.1016/j.celrep.2024.114775_bib53 article-title: Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells publication-title: Nat. Commun. doi: 10.1038/s41467-020-18376-x – reference: 38076921 - bioRxiv. 2024 Jul 10:2023.11.28.569098. doi: 10.1101/2023.11.28.569098 |
SSID | ssj0000601194 |
Score | 2.4186685 |
Snippet | Targeting the distinct metabolic needs of tumor cells has recently emerged as a promising strategy for cancer therapy. The heterogeneous, context-dependent... |
SourceID | doaj unpaywall pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 114775 |
SubjectTerms | Animals cancer metabolism cancer therapies Cell Line, Tumor CP: Cancer CP: Metabolism glioma Humans metabolic state vulnerabilities Mitochondria - metabolism mitochondrial electron transport chain Multivariate Analysis multivariate modeling Neoplasms - genetics Neoplasms - metabolism Neoplasms - pathology Oxidative Phosphorylation PTEN Synthetic Lethal Mutations synthetic lethality |
SummonAdditionalLinks | – databaseName: ScienceDirect Free & Delayed Access Titles dbid: IXB link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqShVcEG9SKDIS17B27F3HR1q1qpDgApX2Zk0chwaF7GofRXvknzPjJEujHoo45rGJH59nvsnOfGbsvQGpgy5CWiF1S7U2Ji2Eh1SoIEEpUypDtcOfv8wur_Sn-XR-wM6GWhhKq-xtf2fTo7Xuz0z60Zws63ryNcPYBb2TQZ9EdTCkCaq0iUV889P9dxbSG5FxP0S6P6UfDBV0Mc3Lh2YVSLgy06Sbayjh8JaHikL-I0d1l4jezad8sG2XsPsFTXPLWV08Zo96lsk_dh15wg5C-5QddftO7p6x37Hs9gbDZGSaHHpdEr6o-M-wQVQ0teex0ojfbBuSpY4ZtBhTc4ht5mXM5gjcE2ZWnPLd0civOelBIZ75etcisYyfyZsdR2hcY2vgLxLWz9nVxfm3s8u034sh9drYDZpqiV4Mw0WlfAYSphZXP7KvYJWHUFbGl6EAafzMqtzLinTTykLkGP0JVaFZfcEO20UbXjFuAXzAwLK0UGprhK1EVlnhZ8jlCgxYEpYO4--WneSGG3LRfrhuvhzNl-vmK2GnNEn7e0kwO55YrL67HjHOl3YawpQUx0qdSw05KOsLZXISEBImYWaYYjfCHz6qvuf17wZEOFya9H8LtGGxXTtkzsYgo52phL3sELJvpLJoaHWOV_IRdka9GF9p6-so_40cXuIzRcI-7GH2TwN1_N99fM0e0hH57Cx7ww43q204QTK2Kd7G1fYH3Yg0WA priority: 102 providerName: Elsevier – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVKEYIL4pvwJSNxTZXEzjo-IASIqkIqJ1bqzZrYDl0UsiXZLeTIP2fGSbZEBcGB62bjeGfeeN5kx8-MvVCQSi9LH1dI3WIplYrLxEKcCJ-CEMoJRXuHjz8sjpby_Ul-ssemM1tHA3a_Le3oPKllWx98_9q_woB_edGrZX3delKfzCSJ3yqVX2FXMTdlhPPjkfAPazNpnMlpD90fbp7lqCDlP0tVl6no5Y7K69vmDPpvUNe_pKvDW-zmyDP56wEYt9meb-6wa8PJk_1d9iNsvD3HQhm5JodRmYSvK_7FbxAX9crysNeIn29rEqYOPbRYVXMIc-Yu9HN4bgk1LaeOd1zmO06KUGhZ3vUNUsvworzuOYLjFGcDF1jo7rHl4buPb4_i8TSG2EqlN7hYp5jHsGAUwmaQQq4x_pF_eS0seFcp63wJqbILLQqbVqSc5sqkwPovERUurPfZfrNu_EPGNYD1WFo6DU5qlegqySqd2AWyuRJLlojFk_3N2SC6YaZutM9m8Jchf5nBXxF7Q07afZcks8MH6_aTGSPQWKdz73PSHHOySCUUILQthSpIQihREVOTi83IPgZWgUOt_vL45xMiDAYn_eMCjV9vO4PcWSnktAsRsQcDQnaTFBqXWlnglWKGndmvmF9pVqdBABxZfIpjJhE72MHsnwz16H8Y6jG7QUNSAs-yJ2x_0279U2Rmm_JZCLafVqw6Vg priority: 102 providerName: Scholars Portal |
Title | Multivariate analysis of metabolic state vulnerabilities across diverse cancer contexts reveals synthetically lethal associations |
URI | https://dx.doi.org/10.1016/j.celrep.2024.114775 https://www.ncbi.nlm.nih.gov/pubmed/39305483 https://www.proquest.com/docview/3107785163 https://pubmed.ncbi.nlm.nih.gov/PMC11511630 https://doi.org/10.1016/j.celrep.2024.114775 https://doaj.org/article/cd95ee50557d4814a8a39cb378017007 |
UnpaywallVersion | publishedVersion |
Volume | 43 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2211-1247 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000601194 issn: 2211-1247 databaseCode: KQ8 dateStart: 20120101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2211-1247 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000601194 issn: 2211-1247 databaseCode: KQ8 dateStart: 20120126 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2211-1247 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000601194 issn: 2211-1247 databaseCode: DOA dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVESC databaseName: ScienceDirect Free & Delayed Access Titles customDbUrl: eissn: 2211-1247 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000601194 issn: 2211-1247 databaseCode: IXB dateStart: 20120126 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2211-1247 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000601194 issn: 2211-1247 databaseCode: DIK dateStart: 20120101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: Geneva Foundation for Medical Education and Research Open Access Journals customDbUrl: eissn: 2211-1247 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000601194 issn: 2211-1247 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 2211-1247 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000601194 issn: 2211-1247 databaseCode: AKRWK dateStart: 20120126 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2211-1247 dateEnd: 20250930 omitProxy: true ssIdentifier: ssj0000601194 issn: 2211-1247 databaseCode: M48 dateStart: 20120101 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQSgguiDfhJSNxDSSxW8dHFrFakJYTK_VmTeyJtiikqz521SP_nBk7Ka32sBy45NBUruP5PPNNOvNZiPcGSo26wbwl6pZrbUzeFB7yQmEJSpmgDPcOn32fnp7rb7PJbO-oL64JS_LAaeE--mAniBOWigq6LjXUoKxvlKlZ-SX1kVMY20umkg9mLTM99srFgi6P3RJZorLSrJBruLRwLxZFyf6DkHSTct6snLy36S9hew1dtxeWTh6KBwOflJ_SczwSd7B_LO6mEya3T8Tv2GB7RQkxcUoJgwKJXLTyF67J_t3cy9hTJK82HQtQx1pZyp4lxDnLEOs2UHpGx1JyZTu585Vk5SdCrlxte6KQ8YV4t5UEgguaDfy1-eqpOD_58uPzaT6cupB7beyanHJJ8YoSQ6V8BSVMLO1z4llolQcMrfEBGyiNn1pV-7JlhbTQFDXleYVqyYE-E0f9oscXQloAj5RCBgtBW1PYtqhaW_gpsbaGUpNM5OP6u8skruHGqrOfLtnLsb1cslcmjtlIu--yNHb8gADjBsC42wCTCTOa2A0sI7EHGmp-y8-_GxHhaBPyPyvQ42KzcsSRjSHuOlWZeJ4QspuksuRSdU136gPsHDzF4Z1-fhGFvomtlzRmkYkPO5j900K9_B8L9Urc5yE5UFfVa3G0Xm7wDTGwdfM2bja6fp0d0_VM138ATWQyYg |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VItReEG-Wp5G4hnVi7zo-0opqC20vtNLeLMdx2qCQXe2j1R7558w4ydKoBxDXeJO1PZ9nvknGnwE-KhtLLzMfFUjdIimVijLubMSFj60QKheK9g6fno0nF_LrdDTdgcNuLwyVVba-v_HpwVu3V4btbA7nZTn8nmDugtFJYUyifTDyHtxHNsCprut4erB90UKCI3E4EJFuiOiObgtdqPNyvlp4Uq5MJAnnKqo4vBWigpJ_L1LdZaJ3Cyr31vXcbm5sVd2KVkeP4GFLM9nnZiSPYcfXT-BBc_Dk5in8CvturzFPRqrJbCtMwmYF--lXCIuqdCxsNWLX64p0qUMJLSbVzIY-szyUc3jmCDQLRgXv6OWXjAShENBsuamRWYb35NWGITausDf2DxSWz-Di6Mv54SRqD2OInFR6hb46xjCG-aIQLrGxHWlc_ki_vBbO-rxQLveZjZUba5G6uCDhtDzjKaZ_XBToV5_Dbj2r_Utg2lrnMbPMtc2lVlwXPCk0d2M0X4YZywCibv7NvNHcMF0x2g_T2MuQvUxjrwEckJG2vyXF7HBhtrg0LWSMy_XI-xFJjuUyjaVNrdAuEyolBSGuBqA6E5seAPFR5V_-_kOHCINrkz642NrP1kuD1FkppLRjMYAXDUK2nRQaPa1MsSXtYac3in5LXV4F_W8k8TE-kw_g0xZm_zRRr_57jO9hb3J-emJOjs--vYZ9aqEAniRvYHe1WPu3yMxW2buw8n4DVyI3eQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Multivariate+analysis+of+metabolic+state+vulnerabilities+across+diverse+cancer+contexts+reveals+synthetically+lethal+associations&rft.jtitle=Cell+reports+%28Cambridge%29&rft.au=Cara+Abecunas&rft.au=Audrey+D.+Kidd&rft.au=Ying+Jiang&rft.au=Hui+Zong&rft.date=2024-10-22&rft.pub=Elsevier&rft.eissn=2211-1247&rft.volume=43&rft.issue=10&rft.spage=114775&rft_id=info:doi/10.1016%2Fj.celrep.2024.114775&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_cd95ee50557d4814a8a39cb378017007 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-1247&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-1247&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-1247&client=summon |